Loss of serum HCV RNA at week 4 of interferon-α therapy is associated with more favorable long-term response in patients with chronic hepatitis C
- 1 June 1995
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 46 (2), 109-115
- https://doi.org/10.1002/jmv.1890460205
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: Definition of optimal conditions for specimen collection and clinical application in interferon-treated patientsHepatology, 1994
- Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis CJournal of Medical Virology, 1994
- Hepatitis C Serotype and Response to Interferon TherapyNew England Journal of Medicine, 1994
- Significance of antibody to the host cellular gene derived epitope GOR in chronic hepatitis C virus infectionJournal of Hepatology, 1993
- Discrepancy between biochemical and virological responses to interferon-$alpha; in chronic hepatitis CThe Lancet, 1993
- Long‐term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis CJournal of Medical Virology, 1993
- Significance of serum hepatitis C virus RNA levels in chronic hepatitis CThe Lancet, 1993
- Detection of hepatitis C virus RNA in patients with chronic hepatitis C virus infections during and after therapy with alpha interferonAntimicrobial Agents and Chemotherapy, 1993
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989